A Journal Sentinel/MedPage Today review of 75 drug industry-funded courses involving testosterone found that half the faculty experts also received direct payments from drug companies as speakers, consultants and advisers.
Homepage Showcase | NPDN, Naples Daily News
Sun, 10/18/2015 - 1:06am
A Journal Sentinel/MedPage Today review of 75 drug industry-funded courses involving testosterone found that half the faculty experts also received direct payments from drug companies as speakers, consultants and advisers.